Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02429362
Other study ID # 14-03383-XP
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2015
Est. completion date June 25, 2020

Study information

Verified date November 2020
Source University of Tennessee
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Subjects are being asked to donate blood, urine, vaginal secretions and/or tissue to a repository for research.This repository will store donated specimens for future research. The Department of Obstetrics and Gynecology at the University of Tennessee Health Science Center, under the direction of Dr. Giancarlo Mari, Professor and Chair, is responsible for the operation of the repository. Additionally, in the case of a stillborn child, the mother will be given the opportunity to donate samples from her stillborn baby's autopsy to a repository for research.


Description:

The stored samples will be used in studies to help researchers understand normal events in pregnancy, as well as events that occur when women and/or their babies have a disease or condition during pregnancy. Additionally, the samples may be used in future studies to develop cell lines for research, create tests to diagnose disease, or develop treatments. A cell line is the result of cells grown outside the body in a laboratory. This process will allow those cells to grow continuously when given the appropriate nutrients and conditions for growth, and will result in a permanent cell culture which is the collection of cells that are grown outside the body in a laboratory. The stored samples will also be used in future studies to help researchers identify genetic influences during pregnancy. Genes are like blueprints in each of your cells that determine traits that you inherit, like eye color and hair color. Genes may also influence what diseases you get and how you respond to treatment. DNA is the substance that makes up your genes. The subject will sign an informed consent for her participation (Primary Informed Consent). In the situation of a stillbirth occurring, the mother of the stillborn baby will sign an informed consent regarding the tissue samples to be obtained during the hospital's routinely performed autopsy. (Secondary Informed Consent).


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date June 25, 2020
Est. primary completion date June 25, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - English speaking female - patients presenting for medical care at the Regional One Health perinatal clinics or Regional One Health Labor and Delivery Dept. will be asked to participate in the study. Exclusion Criteria: - Those not meeting the above criteria.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Tennessee Health Science Center, OB-GYN Memphis Tennessee

Sponsors (3)

Lead Sponsor Collaborator
University of Tennessee Regional One Health, University of Tennessee Regional One Physicians

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal biological sample collection for repository Outcomes will be assessed (including morbidity and mortality associated with the pregnancy/delivery). Studies of specimens may involve examinations for gross pathology, infection, or genomic/proteomic/metabolomic analyses. On average, samples will be collected up to 42 wks of pregnancy & also at time of delivery.
Secondary Stillborn fetal sample collection for repository Outcomes will be assessed (including morbidity and mortality associated with the pregnancy/delivery). Studies of specimens may involve examinations for gross pathology, infection, or genomic/proteomic/metabolomic analyses. At the occurence of a stillbirth, study samples will be collected from the stillborn baby following the hospital's stillborn autopsy policy, on average by the end of 1 week post delivery.
See also
  Status Clinical Trial Phase
Completed NCT04100577 - Today Not Tomorrow Pregnancy and Infant Support Program (TNT- PISP) N/A
Recruiting NCT04154423 - Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study N/A
Active, not recruiting NCT04421235 - Expanding Knowledge About and Evaluating Services for Incarcerated Pregnant and Postpartum Women in Arkansas N/A
Active, not recruiting NCT03215368 - The Ma'Anshan Birth Cohort (MABC)
Recruiting NCT03085875 - POWERMOM, A Healthy Pregnancy Research Community
Active, not recruiting NCT03814395 - Peking University Birth Cohort in Tongzhou
Not yet recruiting NCT06234332 - Peking University Birth Cohort in Weifang (PKUBC-WF)
Completed NCT05073978 - B-vitamin Levels and Adverse Pregnancy Outcomes